The clinical trial met its primary endpoint with extended time to first supplemental injection compared to aflibercept control for both DURAVYU doses. The trial also demonstrated clinically ...
Integrating the two cyber leaders’ platforms brings together the robust endpoint detection and response capabilities of SentinelOne’s market-leading Singularity Endpoint solution and CyberArk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback